Keyphrases
Heart Failure
76%
National Cohort Study
60%
Myocardial Infarction
51%
Confidence Interval
43%
Hazard Ratio
31%
Denmark
31%
All-cause Mortality
29%
Comorbidity
28%
Atrial Fibrillation
27%
Heart Failure Patients
27%
Incidence Rate
25%
Patients with Heart Failure
25%
Noncardiac Surgery
21%
Cardiovascular Mortality
21%
Mortality Risk
21%
Diabetes
20%
Odds Ratio
18%
Beta-blockers
18%
Major Adverse Cardiovascular Events
18%
Coronary Artery Disease
17%
Ischemic Stroke
17%
Framingham Heart Study
16%
Risk Factors
15%
Hypertension
15%
Cardiovascular Risk
15%
Temporal Trends
14%
Adverse Cardiovascular Events
13%
Type 2 Diabetes Mellitus (T2DM)
13%
Coronary Angiography
12%
Body Mass Index
12%
Cardiovascular Disease
12%
Metformin
12%
First-degree Relatives
12%
New-onset Heart Failure
11%
Trends in Incidence
11%
Out-of-hospital Cardiac Arrest
11%
Pharmacotherapy
11%
Aortic Stenosis
10%
Heart Failure Hospitalization
10%
Cardiovascular Events
10%
Register Study
9%
COVID-19
9%
Genetic Risk Score
9%
Ischemic Heart Disease
9%
New Onset
9%
Dilated Cardiomyopathy
9%
Systemic Sclerosis
9%
Multivariable
9%
Nationwide Registry
8%
Lockdown
8%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Cohort Study
58%
Heart Infarction
54%
Cardiovascular Disease
37%
All Cause Mortality
26%
Comorbidity
25%
Atrial Fibrillation
19%
Non Insulin Dependent Diabetes Mellitus
19%
Disease
17%
Ischemic Heart Disease
17%
Brain Ischemia
17%
Prevalence
17%
Obesity
15%
Metformin
12%
Combination Therapy
10%
Beta Adrenergic Receptor Blocking Agent
10%
Diabetes Mellitus
10%
Adverse Event
10%
Malignant Neoplasm
9%
Coronavirinae
9%
Out of Hospital Cardiac Arrest
9%
Aortic Valve Stenosis
8%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Cardiovascular Risk
8%
Adverse Outcome
7%
Mortality Rate
7%
Clopidogrel
7%
Metabolic Disorder
7%
Sulfonylurea
7%
Thromboembolism
7%
Cardiovascular Agent
7%
Warfarin
7%
Cardiovascular Mortality
6%
Pharmacotherapy
6%
Congestive Cardiomyopathy
6%
Renin-Angiotensin System Inhibitor
6%
Aortic Stenosis
5%
Genetic Risk
5%
Loop Diuretic Agent
5%
Anemia
5%
Coronary Artery Disease
5%
Medicine and Dentistry
Heart Failure
69%
Cardiovascular System
39%
Cohort Analysis
27%
Cardiovascular Disease
23%
Atrial Fibrillation
21%
Apoplexy
21%
Diabetes
21%
Hazard Ratio
19%
Noncardiac Surgery
16%
COVID-19
14%
Prevalence
12%
Brain Ischemia
11%
Coronary Artery Disease
11%
All Cause Mortality
11%
Myocardial Infarction
11%
Coronary Angiography
11%
Malignant Neoplasm
10%
Glycon
9%
Systemic Scleroderma
9%
Genetic Risk
9%
Maturity Onset Diabetes of the Young
9%
Ischemic Heart Disease
9%
Mortality Rate
8%
Diabetes Mellitus
8%
Aortic Stenosis
8%
Odds Ratio
8%
Adverse Event
7%
Aortic Valve Stenosis
7%
Heart Left Ventricle Ejection Fraction
7%
Meta-Analysis
7%
Body Mass Index
7%
Cohort Effect
7%
Dilated Cardiomyopathy
7%
Proportional Hazards Model
6%
Child
6%
Disease
5%
Cardiovascular Risk
5%
Adverse Outcome
5%
Revascularization
5%
Logistic Regression Analysis
5%
